Context Therapeutics Inc (CNTX)
1.92
-0.06
(-3.03%)
USD |
NASDAQ |
Oct 04, 16:00
1.93
+0.01
(+0.52%)
After-Hours: 20:00
Context Therapeutics Shareholders Equity (Annual): 11.87M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.87M |
| December 31, 2022 | 34.76M |
| December 31, 2021 | 48.27M |
| Date | Value |
|---|---|
| December 31, 2020 | -16.92M |
| December 31, 2019 | -23.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-23.96M
Minimum
2019
48.27M
Maximum
2021
10.80M
Average
11.87M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Collegium Pharmaceutical Inc | 195.43M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |